Literature DB >> 9154394

Candida: a review of clinical experience with Lamisil.

N Zaias1.   

Abstract

Pharmaceutical companies sometimes quote the MICs of antifungal agents to make favourable or unfavourable comparisons with competitor drugs. To the doctor, however, the clinical outcome is important. In this light it can be seen that topical terbinafine is certainly as effective as, if not more effective than, any other anticandidal agent available.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9154394     DOI: 10.1159/000246176

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts.

Authors:  N S Ryder; S Wagner; I Leitner
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

2.  Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae.

Authors:  Regina Leber; Sandra Fuchsbichler; Vlasta Klobucníková; Natascha Schweighofer; Eva Pitters; Kathrin Wohlfarter; Mojca Lederer; Karina Landl; Christoph Ruckenstuhl; Ivan Hapala; Friederike Turnowsky
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.